Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02TJT
|
||||
Former ID |
DNCL003833
|
||||
Drug Name |
MK-8109
|
||||
Indication | Platinum-resistant ovarian cancer [ICD9: 140-229, 183; ICD10:C56] | Phase 3 | [549855] | ||
Company |
Merck
|
||||
Target and Pathway | |||||
Target(s) | Folate receptor alpha | Target Info | Modulator | [544488] | |
KEGG Pathway | Endocytosis | ||||
WikiPathways | Folate Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.